Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000498717 | SCV000590538 | pathogenic | not provided | 2017-06-19 | criteria provided, single submitter | clinical testing | The Q522X variant in the MME gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Q522X variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret Q522X as a pathogenic variant. |
Ce |
RCV000498717 | SCV004148585 | pathogenic | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | MME: PVS1, PM2 |
Institute of Medical Genetics and Applied Genomics, |
RCV001290399 | SCV005184169 | pathogenic | Charcot-Marie-Tooth disease axonal type 2T | 2024-08-07 | criteria provided, single submitter | clinical testing | |
Human Genetics Research Center, |
RCV001290399 | SCV001469087 | pathogenic | Charcot-Marie-Tooth disease axonal type 2T | 2021-01-02 | no assertion criteria provided | clinical testing |